AstraZeneca PLC (AZN) — Stock analysis
GBpCurrent price
13.802,00 £
66,00 £ (+0.48%) today
Market signals
About AstraZeneca PLC
AstraZeneca is one of the world's largest biopharmaceuticals, formed in 1999 by the merger of Astra AB (Sweden) and Zeneca Group (UK). Main therapeutic areas are oncology (Tagrisso, Imfinzi, Enhertu), cardiovascular-renal-metabolism (Farxiga, Brilique), respiratory and immunology (Symbicort, Fasenra) and vaccines. Headquartered in Cambridge (UK). Listed on LSE (AZN) and NASDAQ (AZN).
What does AstraZeneca do?▾
AstraZeneca develops and markets drugs in oncology (one of the world leaders), cardiology, diabetes, respiratory diseases and vaccines. The oncology portfolio (Tagrisso for NSCLC, Enhertu, Imfinzi) is now the primary growth driver. It produced the COVID-19 vaccine Vaxzevria with Oxford.
Which exchange is AstraZeneca listed on?▾
AstraZeneca is listed on the London Stock Exchange with ticker AZN and is dual-listed on NASDAQ with the same ticker. It is a FTSE 100 component.
Does AstraZeneca pay dividends?▾
Yes. It pays a growing semiannual dividend in US dollars. Yield is typically 1.5–2%.
Analyse this stock with AI
Create a free account and get 2 credits to generate a complete analysis.
Create account · 2 free credits